Insider Trading activities of Odonate Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Odonate Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Odonate Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Odonate Therapeutics, Inc. since 2005. The reporting company's ticker symbol is ODT. The reporting company's CIK number is 1717452.
The total value of stock buying since 2005 is $63,211,317.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Odonate Therapeutics, Inc. (ODT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-09 90,000 $1,759,311 0 $0 0 $0
2018-08 80,000 $1,545,163 0 $0 0 $0
2018-03 204,401 $4,667,802 0 $0 0 $0
2018-02 176,987 $4,215,789 0 $0 0 $0
2017-12 2,125,998 $51,023,252 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Odonate Therapeutics, Inc. insiders (ODT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-09-20 Lemkey John G (Chief Financial Officer) Buy 27,983 20.09 562,066
2018-09-19 Lemkey John G (Chief Financial Officer) Buy 12,017 19.39 233,045
2018-09-18 Lemkey John G (Chief Financial Officer) Buy 50,000 19.28 964,200
2018-08-21 Lemkey John G (Chief Financial Officer) Buy 7,505 19.47 146,152
2018-08-20 Lemkey John G (Chief Financial Officer) Buy 10,108 18.96 191,617
2018-08-17 Lemkey John G (Chief Financial Officer) Buy 2,387 19.26 45,980
2018-08-16 Lemkey John G (Chief Financial Officer) Buy 37,190 19.63 730,188
2018-08-15 Lemkey John G (Chief Financial Officer) Buy 9,416 18.98 178,762
2018-08-14 Lemkey John G (Chief Financial Officer) Buy 6,603 18.98 125,351
2018-08-13 Lemkey John G (Chief Financial Officer) Buy 6,791 18.72 127,113
2018-03-26 Davis Aaron I. (Director) Buy 33,650 22.41 754,096
2018-03-26 Lewis Joseph (10% Owner) Buy 33,650 22.41 754,096
2018-03-23 Davis Aaron I. (Director) Buy 42,943 23.96 1,028,914
2018-03-23 Lewis Joseph (10% Owner) Buy 42,943 23.96 1,028,914
2018-03-22 Davis Aaron I. (Director) Buy 23,407 20.94 490,142
2018-03-22 Lewis Joseph (10% Owner) Buy 23,407 20.94 490,142
2018-03-01 Lemkey John G (Chief Financial Officer) Buy 4,401 27.61 121,498
2018-02-28 Lemkey John G (Chief Financial Officer) Buy 9,649 27.38 264,218
2018-02-22 Lemkey John G (Chief Financial Officer) Buy 17,338 27.62 478,962
2018-02-21 Lemkey John G (Chief Financial Officer) Buy 13,432 27.84 373,879
2018-02-20 Lemkey John G (Chief Financial Officer) Buy 8,313 25.15 209,088
2018-02-16 Lemkey John G (Chief Financial Officer) Buy 57,364 24.21 1,388,725
2018-02-15 Lemkey John G (Chief Financial Officer) Buy 34,943 21.98 768,082
2018-02-14 Lemkey John G (Chief Financial Officer) Buy 35,948 20.39 732,835
2017-12-12 Vacirca Jeff L (Director) Buy 1,000 23.30 23,300
2017-12-07 Lemkey John G (Chief Financial Officer) Buy 1,291,666 24.00 30,999,984
2017-12-06 Davis Aaron I. (Director) Buy 416,666 24.00 9,999,984
2017-12-06 Lewis Joseph (10% Owner) Buy 416,666 24.00 9,999,984

Insider trading activities including stock purchases, stock sales, and option exercises of ODT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Odonate Therapeutics, Inc. (symbol ODT, CIK number 1717452) see the Securities and Exchange Commission (SEC) website.